Vincristine Sulfate · DIN 02143305 · 1 mg/mL · injection solution
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Vincristine Sulfate · DIN 02143305
Manufacturer: Novopharm Ltd.; listing date 1996-10-01
Health Canada: Marketed since 2014-04-12 · brand VINCRISTINE SULFATE INJECTION · ATC L01CA02 VINCRISTINE · form Solution · route Intravenous · ingredients VINCRISTINE SULFATE 1 MG/ML · company Teva canada limited · schedule Prescription
Vincristine Sulfate: Formulary list price $30.60 per unit (the source does not state the unit; exact figure $30.6000). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02143305)
Source record
DIN 02143305: Vincristine Sulfate
Raw flags: sec3=Y
Item: 100000049; group id 189; item number 0347; lccId None; manufacturer id NOP
Source form: Inj Sol; strength: 1mg/mL
Recorded listing: General benefit
Source prices (unrounded): $30.6000; ministry $30.6000
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02143305
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=19756
Interchangeable products
Oncovin · DIN 00611182 · not recorded
Shortage status: not checked (no credentials)